公司概覽
業務類別 Biotechnology
業務概覽 Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
公司地址 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA, USA, 92130
電話號碼 +1 858 751-4493
傳真號碼 --
公司網頁 https://www.januxrx.com
員工數量 109
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Janeen Noel Doyle Chief Corporate Business Development Officer and Interim Principal Accounting Officer -- 26/02/2026
Dr. David Campbell, PhD Director, President and Chief Executive Officer 美元 646.00K 26/02/2026
Mr. Andy Meyer Chief Business Officer -- 25/04/2025
Mr. Zachariah McIver Chief Medical Officer -- 25/04/2025
Mr. Charles M. Winter Chief Technical Officer -- 25/04/2025
Dr. Thomas DiRaimondo, PhD Chief Scientific Officer 美元 420.00K 25/04/2025
Ms. Maria Dobek Vice President, Accounting and Principal Accounting Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Ronald W. Barrett, PhD Chairman of the Board 26/02/2026
Mr. Winston Kung, M.B.A. Independent Director 26/02/2026
Ms. Vickie L. Capps Independent Director 26/02/2026
Ms. Natasha A. Hernday Independent Director 26/02/2026
Dr. Sheila Gujrathi, M.D. Independent Director 26/02/2026
Mr. Eric L. Dobmeier, J.D. Independent Director 26/02/2026
Dr. David Campbell, PhD Director, President and Chief Executive Officer 26/02/2026
Dr. Jake Simson, PhD Independent Director 26/02/2026
Ms. Alana B. McNulty Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:54)
代號 名稱 佔比% 持有日期
TECBiShares US Tech Breakthrough Mltsctr ETF0.01%28/02/2026
WSMLiShares MSCI World Small-Cap ETF0.01%28/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
TMEDT. Rowe Price Health Care ETF0.005%28/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
UWMProShares Ultra Russell20000.004%27/02/2026
URTYProShares UltraPro Russell20000.004%27/02/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%28/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
ESSCEventide Small Cap ETF0.003%27/02/2026
DXUVDimensional US Vector Equity ETF0.002%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.001%25/02/2026
AVUSAvantis US Equity ETF0.001%28/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.0003%27/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0001%31/05/2023
HDGProShares Hedge Replication0.0001%27/02/2026
BKSEBNY Mellon US Small Cap Core Equity ETF<0.000001%07/08/2025
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.